OXYCONTIN (oxycodone hydrochloride) Purdue pharma lp Patent: 12,060,361 Expiration: Mar 30, 2025 See More … For more information on how […]
Drug Patent Expirations for the Week of March 30, 2025 Read Post »
XTAMPZA ER (oxycodone) Collegium pharm inc Patent: 7,771,707 Expiration: Mar 24, 2025 See More … For more information on how
Drug Patent Expirations for the Week of March 23, 2025 Read Post »
LUMIGAN (bimatoprost) Abbvie Patent: 8,524,777 Expiration: Mar 16, 2025 See More … For more information on how DrugPatentWatch can help
Drug Patent Expirations for the Week of March 16, 2025 Read Post »
YUPELRI (revefenacin) Mylan ireland ltd Patent: 7,491,736 Expiration: Mar 10, 2025 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of March 9, 2025 Read Post »
YUPELRI (revefenacin) Mylan ireland ltd Patent: 7,521,041 Expiration: Mar 10, 2025 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of March 9, 2025 Read Post »
UTIBRON (glycopyrrolate; indacaterol maleate) Novartis Patent: 6,878,721 Expiration: Feb 25, 2025 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of February 23, 2025 Read Post »
DURYSTA (bimatoprost) Abbvie Patent: 8,673,341 Expiration: Feb 19, 2025 See More … For more information on how DrugPatentWatch can help
Drug Patent Expirations for the Week of February 16, 2025 Read Post »
EPANOVA (omega-3-carboxylic acids) Astrazeneca Patent: 9,132,112 Expiration: Feb 7, 2025 See More … For more information on how DrugPatentWatch can
Drug Patent Expirations for the Week of February 2, 2025 Read Post »
EPANOVA (omega-3-carboxylic acids) Astrazeneca Patent: 9,132,112 Expiration: Feb 7, 2025 See More … For more information on how DrugPatentWatch can
Drug Patent Expirations for the Week of February 2, 2025 Read Post »
Get fresh news and insights, drug patent expirations & more…
